Detalhe da pesquisa
1.
In vitro evidence of human immune responsiveness shows the improved potential of a recombinant BCG strain for bladder cancer treatment
Front. immunol.
; 10: 1460, 2019.
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: but-ib16085
2.
In vitro evidence of human immune responsiveness shows the improved potential of a recombinant BCG strain for bladder cancer treatment
Front immunol, v. 10, p. 1460, jun. 2019
Artigo
Inglês
| SES-SP, SES SP - Instituto Butantan, SES-SP | ID: bud-2789